Benitec BiopharmaBNTC
13F holders, Q1 2024 (March 31)13holders
$5.18avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings. The largest holders were Franklin Resources Inc. ($3.0M), Janus Henderson Group PLC ($1.3M) and Montanova Capital, LLC ($1.1M).
- Company
- Benitec Biopharma Inc.
- CUSIP
- 08205P209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 13 holders
| Franklin Resources Inc. | 0.00% | Add +0.0% | 588,310 | $3.0M |
| Janus Henderson Group PLC | 0.00% | Add +35.5% | 244,491 | $1.3M |
| Montanova Capital, LLC | 0.05% | No change | 204,220 | $1.1M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 189,188 | $993K |
| Vanguard Group Inc. | 0.00% | No change | 16,701 | $88K |
| Morgan Stanley | 0.00% | Add +131.4% | 11,800 | $62K |
| Geode Capital Management, LLC | 0.00% | No change | 10,024 | $51K |
| GAMMA Investing LLC | 0.00% | Add +954.6% | 3,554 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.1% | 1,745 | $9K |
| UBS Group AG | 0.00% | Reduce -17.7% | 512 | $3K |
| Rhumbline Advisers | 0.00% | No change | 186 | $952 |
| Group One Trading LLC | 0.00% | No change | 89 | $456 |
| Wells Fargo & Company | 0.00% | No change | 17 | $89 |
"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.